Evidence map›Paper›PMID 27210535›Full record

ReviewJournal of clinical immunology2016

Autoimmunity and Primary Immunodeficiency Disorders.

Eric Allenspach, Troy R Torgerson

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06876337 (Frequency of Skin Diseases in Children with Inborn Errors of Immunity), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06876337 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Frequency of Skin Diseases in Children with Inborn Errors of Immunity

TypeobservationalSponsorAssiut UniversityRan2025 to 2026Enrolled60ConditionsSkin Condition
3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Development of autoimmunity in patients with primary immunodeficiencies].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Chronic Lung Disease in Primary Antibody Deficiency: Diagnosis and Management.Immunology and allergy clinics of North America · 2020
    Review
  15. Review
  16. The five dimensions of B cell tolerance.Immunological reviews · 2019
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eric AllenspachDepartment of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
Troy R TorgersonDepartment of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA. troy.torgerson@seattlechildrens.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in DNA sequencing technologies have led to a quickening in the pace at which new genetic immunodeficiency disorders have been identified. Among the newly identified defects are a number of disorders that present primarily with autoimmunity as opposed to recurrent infections. These "immune dysregulation" disorders have begun to cluster together to form an increased understanding of some of the basic molecular mechanisms that underlie the establishment and maintenance of immune tolerance and the development of autoimmunity. This review will present three major themes that have emerged in our understanding of the mechanisms that underlie autoimmunity and immune dysregulation in humans.

Indexed as

AutoimmunityAnimalsAutoimmune DiseasesHost-Pathogen InteractionsHumansImmunity, InnateImmunologic Deficiency SyndromesOrgan SpecificitySignal TransductionT-Lymphocyte SubsetsCTLA4—cytotoxic T lymphocyte-associated protein 4CVID—common variable immune deficiencyIL-10—interleukin-10IPEX—immune dysregulation, polyendocrinopathy, enteropathy, X-linkedNF-κB—nuclear factor-kappa bindingPIDD—primary immunodeficiency disordersSTAT—signal transducer and activator of transcriptionTreg—regulatory T cell

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.